CN111795909A - A kind of method of screening ice control material - Google Patents
A kind of method of screening ice control material Download PDFInfo
- Publication number
- CN111795909A CN111795909A CN201910282418.9A CN201910282418A CN111795909A CN 111795909 A CN111795909 A CN 111795909A CN 201910282418 A CN201910282418 A CN 201910282418A CN 111795909 A CN111795909 A CN 111795909A
- Authority
- CN
- China
- Prior art keywords
- ice
- temperature
- control material
- adsorption
- screening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 95
- 238000000034 method Methods 0.000 title claims abstract description 34
- 238000012216 screening Methods 0.000 title claims abstract description 19
- 238000001179 sorption measurement Methods 0.000 claims abstract description 57
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000002474 experimental method Methods 0.000 claims abstract description 18
- 239000005457 ice water Substances 0.000 claims abstract description 16
- 239000013078 crystal Substances 0.000 claims abstract description 15
- 230000007480 spreading Effects 0.000 claims abstract description 10
- 238000003892 spreading Methods 0.000 claims abstract description 10
- 239000000243 solution Substances 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 31
- 239000007864 aqueous solution Substances 0.000 claims description 24
- 239000000110 cooling liquid Substances 0.000 claims description 19
- 238000003860 storage Methods 0.000 claims description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 238000007710 freezing Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- 238000004781 supercooling Methods 0.000 claims description 6
- 239000006185 dispersion Substances 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 239000004020 conductor Substances 0.000 claims description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 3
- 238000000870 ultraviolet spectroscopy Methods 0.000 claims description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 2
- 235000011089 carbon dioxide Nutrition 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 230000036571 hydration Effects 0.000 claims description 2
- 238000006703 hydration reaction Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000011550 stock solution Substances 0.000 claims 4
- 238000010992 reflux Methods 0.000 claims 2
- 239000002826 coolant Substances 0.000 claims 1
- 239000012809 cooling fluid Substances 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 230000002528 anti-freeze Effects 0.000 abstract 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 67
- 125000000914 phenoxymethylpenicillanyl group Chemical group CC1(S[C@H]2N([C@H]1C(=O)*)C([C@H]2NC(COC2=CC=CC=C2)=O)=O)C 0.000 description 21
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 21
- 238000005138 cryopreservation Methods 0.000 description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 15
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 12
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- 210000000287 oocyte Anatomy 0.000 description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 8
- 229930006000 Sucrose Natural products 0.000 description 8
- 239000005720 sucrose Substances 0.000 description 8
- 238000010257 thawing Methods 0.000 description 8
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 108010053481 Antifreeze Proteins Proteins 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000002296 dynamic light scattering Methods 0.000 description 3
- 230000035558 fertility Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000000329 molecular dynamics simulation Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000004017 vitrification Methods 0.000 description 2
- 241001150538 Iria Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000002977 biomimetic material Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N5/00—Analysing materials by weighing, e.g. weighing small particles separated from a gas or liquid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N13/00—Investigating surface or boundary effects, e.g. wetting power; Investigating diffusion effects; Analysing materials by determining surface, boundary, or diffusion effects
- G01N2013/003—Diffusion; diffusivity between liquids
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Description
技术领域technical field
本发明属于生物医用材料技术领域,具体涉及一种筛选控冰材料的方法。The invention belongs to the technical field of biomedical materials, and particularly relates to a method for screening ice-controlling materials.
背景技术Background technique
冷冻保存是指将生物材料保存于超低温状态下,使细胞新陈代谢和分裂速度减慢或者停止,一旦恢复正常生理温度又能继续发育。该技术自问世以来,成为自然科学领域不可缺少的研究方法之一,已被广泛采用。近年来,随着生活压力的增加,人类生育力呈逐年下降的趋势,生育力保存越来越受到人们的重视,人类生殖细胞(精子、卵母细胞)、性腺组织等的冷冻保存就成为保存生育力的重要手段。另外,随着世界人口老龄化加剧,对捐赠的可用于再生医学和器官移植的人源性材料的冷冻保存的需求也极速增加。因此,如何高效的冷冻保存珍贵的细胞、组织以及器官资源以备不时之需成为亟待解决的科学技术问题。Cryopreservation refers to the preservation of biological materials under ultra-low temperature, which slows down or stops cell metabolism and division, and can continue to develop once the normal physiological temperature is restored. Since its inception, this technology has become one of the indispensable research methods in the field of natural sciences and has been widely used. In recent years, with the increase of life pressure, human fertility has been declining year by year, and fertility preservation has attracted more and more attention. The cryopreservation of human germ cells (sperm, oocytes), gonadal tissue, etc. important means of fertility. In addition, as the world's population ages, the need for cryopreservation of donated human-derived materials that can be used in regenerative medicine and organ transplantation is rapidly increasing. Therefore, how to efficiently cryopreserve precious cells, tissues and organ resources for emergencies has become an urgent scientific and technical problem to be solved.
目前最常用的冷冻保存方法为玻璃化冷冻。玻璃化冷冻技术采用渗透性或非渗透性低温保护剂,虽然在快速冷冻过程中可使细胞内外的液体直接成为玻璃态而避免了冷冻过程中因冰晶形成而导致的损伤。但是,在复温过程中,现有的冷冻保存试剂不能有效的控制冰晶的生长,从而损害细胞。由于抗冻蛋白和仿生控冰材料在分子层面的控冰机制仍有争议,仿生控冰材料的研发只能依赖“试误法”逐步尝试某种控冰材料的控冰效果,工作量大,成功几率渺茫,所以还需探索出仿生材料控冰机制的一般性原则和筛选方法。The most commonly used cryopreservation method is vitrification. The vitrification technology uses permeable or non-permeable cryoprotectants, although the liquid inside and outside the cell can be directly turned into a glass state during the rapid freezing process to avoid the damage caused by the formation of ice crystals during the freezing process. However, during the rewarming process, the existing cryopreservation reagents cannot effectively control the growth of ice crystals, thereby damaging the cells. Since the ice control mechanism of antifreeze proteins and bionic ice control materials at the molecular level is still controversial, the research and development of bionic ice control materials can only rely on the "trial and error method" to gradually try the ice control effect of a certain ice control material, which requires a lot of work. The chances of success are slim, so it is still necessary to explore the general principles and screening methods for the ice control mechanism of biomimetic materials.
发明内容SUMMARY OF THE INVENTION
本发明提供一种筛选控冰材料的方法,包括如下步骤:(1)测得所述控冰材料与水的亲和性;(2)测得所述控冰材料在冰水界面的铺展性能。The present invention provides a method for screening ice-controlling materials, comprising the following steps: (1) measuring the affinity of the ice-controlling material with water; (2) measuring the spreading performance of the ice-controlling material at the ice-water interface .
作为本发明的一个实施方案,所述步骤(1)可以通过测定所述控冰材料在水中的溶解度、水合常数、分散尺寸、扩散系数等、和/或计算所述控冰材料与水分子形成的分子间氢键数等方法测定;具体地,例如采用分子动力学模拟(Molecular dynamics simulation,MD)测定所述控冰材料分子与水分子形成的分子间氢键数,或者采用动态光散射测定所述控冰材料在水溶液中的分散尺寸。As an embodiment of the present invention, the step (1) can be performed by measuring the solubility, hydration constant, dispersion size, diffusion coefficient, etc. of the ice-controlling material in water, and/or calculating the formation of the ice-controlling material with water molecules Methods such as the number of intermolecular hydrogen bonds to measure; Specifically, for example, adopt molecular dynamics simulation (Molecular dynamics simulation, MD) to measure the number of intermolecular hydrogen bonds formed by the ice control material molecule and water molecule, or adopt dynamic light scattering to measure The dispersion size of the ice control material in the aqueous solution.
作为本发明的一个实施方案,所述步骤(2)可以通过测定在冰水界面处所述控冰材料在冰表面的吸附含量得到所述材料在冰水界面的铺展性能,和/或计算所述控冰材料与冰-水分子形成的分子间氢键数等方法测定所述材料与冰的亲和性;具体地,例如采用MD模拟测定所述控冰分子与冰-水分子形成的分子间氢键数,或者采用冰吸附实验于冰水界面处测得所述控冰材料分子在冰表面的吸附量。As an embodiment of the present invention, the step (2) can obtain the spreading performance of the material at the ice-water interface by measuring the adsorption content of the ice-controlling material on the ice surface at the ice-water interface, and/or calculate the The affinity of the material and ice is determined by methods such as the number of intermolecular hydrogen bonds formed by the ice-controlling material and ice-water molecules; specifically, for example, MD simulation is used to determine the molecules formed by the ice-controlling molecules and ice-water molecules. The number of hydrogen bonds between the two, or the adsorption amount of the ice-controlling material molecules on the ice surface is measured at the ice-water interface using an ice adsorption experiment.
根据本发明,所述冰吸附实验包括测得所述控冰材料在冰表面的吸附量。According to the present invention, the ice adsorption experiment includes measuring the adsorption amount of the ice control material on the ice surface.
根据本发明,所述控冰材料在冰表面的吸附量=(冰表面所吸附的控冰材料质量m1/含有控冰材料的原溶液中控冰材料的总质量m2)╳100%。According to the present invention, the adsorption amount of the ice control material on the ice surface=(mass m 1 of the ice control material adsorbed on the ice surface/total mass m 2 of the ice control material in the original solution containing the ice control material)╳100%.
作为本发明的一个实施方案,所述冰吸附实验包括以下步骤:As an embodiment of the present invention, the ice adsorption experiment includes the following steps:
S1:取质量为m2的控冰材料,配制所述控冰材料的水溶液,降温至过冷温度;S1: get the ice-controlling material that quality is m , prepare the aqueous solution of described ice-controlling material, be cooled to supercooling temperature;
S2:将预冷的控温棒置于所述水溶液中诱导冰层在控温棒表面生长,持续搅拌水溶液,以待控冰材料逐渐吸附于冰层表面,保持水溶液、控温棒温度在过冷温度;S2: place the pre-cooled temperature control rod in the aqueous solution to induce the growth of an ice layer on the surface of the temperature control rod, continuously stir the aqueous solution, gradually adsorb the ice control material on the surface of the ice layer, and keep the temperature of the aqueous solution and the temperature control rod at a higher temperature than that of the temperature control rod. cold temperature;
S3:测定控冰材料在冰表面的吸附量。S3: Measure the adsorption amount of the ice control material on the ice surface.
根据本发明的实施方案,所述控温棒为导热材料制得的棒状物。所述棒状物可以是实心的或者中空的。当所述控温棒为中空的,其中空内腔有冷却液流动,可以通过控制冷却液的温度控制控温棒的温度,从而控制冰块的生长速度。According to an embodiment of the present invention, the temperature control rod is a rod made of a thermally conductive material. The rod may be solid or hollow. When the temperature control rod is hollow, and a cooling liquid flows in the hollow cavity, the temperature of the temperature control rod can be controlled by controlling the temperature of the cooling liquid, thereby controlling the growth rate of the ice cubes.
根据本发明的实施方案,所述控温棒可经液氮、干冰、超低温冰箱冷冻等方式中的一种预冷。According to an embodiment of the present invention, the temperature control rod can be pre-cooled by one of liquid nitrogen, dry ice, freezing in an ultra-low temperature refrigerator, and the like.
根据本发明的实施方案,所述冰吸附实验过程中,保持过冷度以及吸附时间不变以使控温棒表面所得冰的表面积在误差允许范围内保持不变。According to an embodiment of the present invention, during the ice adsorption experiment, the subcooling degree and the adsorption time are kept constant so that the surface area of the ice obtained on the surface of the temperature control rod remains constant within the allowable error range.
根据本发明的实施方案,配置不同浓度的控冰材料的水溶液,进行冰吸附实验,可以评估同一控冰材料在具体应用时的适用浓度范围。According to the embodiment of the present invention, by configuring aqueous solutions of ice-controlling materials with different concentrations, and performing ice adsorption experiments, the applicable concentration range of the same ice-controlling material in specific applications can be evaluated.
根据本发明的实施方案,所述步骤S1中控冰材料可以为预先荧光标记的,例如用荧光素进行标记,所述荧光素可以选自异硫氰酸荧光素(FITC)、四乙基罗丹明(RB200)、四甲基异硫氰酸罗丹明(TRITC)、碘化丙啶(PI)等中的至少一种。本领域技术人员应当理解,所述荧光标记的作用在于测得所述控冰材料的量,因此,如果所述控冰材料的吸附量可以通过其他方式准确测量,或者材料本身具有紫外或荧光光谱吸收特性,则无需进行荧光标记。According to an embodiment of the present invention, the ice control material in the step S1 may be pre-fluorescently labeled, for example, labeled with fluorescein, and the fluorescein may be selected from fluorescein isothiocyanate (FITC), tetraethylrhodane At least one of rhodamine (RB200), tetramethylisothiocyanate (TRITC), propidium iodide (PI) and the like. Those skilled in the art should understand that the function of the fluorescent label is to measure the amount of the ice control material, therefore, if the adsorption amount of the ice control material can be accurately measured by other means, or if the material itself has an ultraviolet or fluorescence spectrum absorption properties, no fluorescent labeling is required.
根据本发明的实施方案,步骤S3包括:According to an embodiment of the present invention, step S3 comprises:
S3a:将吸附完成的冰块取出,纯水淋洗冰表面,融化冰块得到控冰材料吸附溶液;S3a: take out the ice cubes that have been adsorbed, rinse the ice surface with pure water, and melt the ice cubes to obtain the ice-controlling material adsorption solution;
S3b:测定融化的控冰材料吸附溶液的体积V,测定所述吸附溶液中控冰材料的质量/体积浓度c,通过公式m1=cV计算得到冰表面所吸附的控冰材料质量m1。S3b: Measure the volume V of the melted ice-controlling material adsorption solution, measure the mass/volume concentration c of the ice-controlling material in the adsorption solution, and calculate the mass m1 of the ice-controlling material adsorbed on the ice surface by formula m 1 =cV.
根据本发明的实施方案,所述S3b中,所述浓度c可通过本领域已知的方法测得,例如紫外可见光谱法、荧光光谱法等。According to an embodiment of the present invention, in the S3b, the concentration c can be measured by methods known in the art, such as ultraviolet-visible spectroscopy, fluorescence spectroscopy, and the like.
根据本发明,所述方法用于控制冰晶生长材料的筛选,例如PVA、聚氨基酸、抗冻蛋白、多肽等。According to the present invention, the method is used for the screening of controlled ice crystal growth materials, such as PVA, polyamino acids, antifreeze proteins, polypeptides, and the like.
根据本发明,所述方法还包括步骤(3):评估所述材料与水的亲和性和在冰水界面的铺展性能,铺展能力强的材料具有良好的控冰性能。According to the present invention, the method further includes step (3): evaluating the affinity of the material with water and the spreading performance at the ice-water interface, and the material with strong spreading ability has good ice control performance.
作为本发明步骤(3)的一个具体评估方案,覆盖一定冰表面积所需控冰材料的用量越小,则说明其铺展性能越好,即满足铺展系数S>0,其中S=γI-W-(γIRIA-I+γIRIA-W),γI-W为常数,即,冰水界面能γI-W大于材料与冰以及材料与水的界面能之和γIRIA-I+γIRIA-W(γIRIA-I:材料与冰的界面能;γIRIA-W:材料与水的界面能)。As a specific evaluation scheme of step (3) of the present invention, the smaller the amount of ice-controlling material needed to cover a certain ice surface area, the better the spreading performance, that is, the spreading coefficient S>0 is satisfied, where S=γ IW −( γ IRIA -I+γIRIA -W ), γ IW is a constant, that is, the ice-water interface energy γ IW is greater than the sum of the interfacial energies between material and ice and material and water γ IRIA-I +γ IRIA-W (γ IRIA-I : the interface energy between the material and ice; γ IRIA-W : the interface energy between the material and water).
本发明中,过冷温度是指低于水的凝固点但仍不凝固或结晶的温度,在室温25℃时,所述过冷温度一般在-0.01~-0.5℃范围内,例如-0.1℃。-In the present invention, the supercooling temperature refers to a temperature lower than the freezing point of water but still not solidified or crystallized. When the room temperature is 25°C, the supercooling temperature is generally in the range of -0.01 to -0.5°C, such as -0.1°C. -
本发明还提供一种冰吸附实验装置,包括多层储液腔、控温棒和温度控制器,所述多层储液腔由里到外依次包括冰吸附腔、温浴腔、冷却液储存腔,所述控温棒置于冰吸附腔内,所述控温棒和储液腔的温度由温度控制器控制。The invention also provides an ice adsorption experiment device, which includes a multi-layer liquid storage chamber, a temperature control rod and a temperature controller. The multi-layer liquid storage chamber sequentially includes an ice adsorption chamber, a warm bath chamber and a cooling liquid storage chamber from inside to outside , the temperature control rod is placed in the ice adsorption chamber, and the temperature of the temperature control rod and the liquid storage chamber is controlled by a temperature controller.
根据本发明的冰吸附实验装置,所述控温棒为导热材料制成的中空结构,所述控温棒的中空结构设置有进液口和排液口;所述温度控制器为流体温控器,所述温度控制器设置有冷却液流出端和回流端;所述冷却液储存腔两端设置有进液口和排液口;所述温度控制器的冷却液流出端、控温棒的进液口、控温棒的排液口、冷却液储存箱的进液口、冷却液储存箱的排液口以及温度控制器的回流端依次经管道连通,所述管道内流动冷却液。According to the ice adsorption experimental device of the present invention, the temperature control rod is a hollow structure made of thermally conductive material, and the hollow structure of the temperature control rod is provided with a liquid inlet and a liquid discharge port; the temperature controller is a fluid temperature control The temperature controller is provided with a cooling liquid outflow end and a return end; both ends of the cooling liquid storage cavity are provided with a liquid inlet and a liquid discharge port; the cooling liquid outflow end of the temperature controller, the temperature control rod The liquid inlet, the liquid discharge port of the temperature control rod, the liquid inlet of the cooling liquid storage tank, the liquid discharge port of the cooling liquid storage tank and the return end of the temperature controller are sequentially connected through a pipeline, and the cooling liquid flows in the pipeline.
根据本发明的冰吸附实验装置,所述多层储液腔设有盖子。According to the ice adsorption experimental device of the present invention, the multi-layer liquid storage chamber is provided with a cover.
使用时,所述冰吸附腔内盛放控冰材料的水溶液,中层温浴腔装有预定温度的温浴介质例如水浴、冰浴或者油浴等;冷却液温度达到设定温度后,经温度控制器流出,流入中空的控温棒中空结构,对控温棒温度实现控制,随后从控温棒排液口流出,再流入外层冷却液储存腔保持温浴介质的温度在预定水平,再经冷却液储存箱的排液口流经温度控制器的回流端进入温度控制器循环。When in use, the ice adsorption chamber is filled with an aqueous solution of the ice-controlling material, and the middle-layer temperature bath chamber is equipped with a temperature bath medium with a predetermined temperature, such as a water bath, an ice bath or an oil bath, etc.; It flows out and flows into the hollow structure of the hollow temperature control rod to control the temperature of the temperature control rod, and then flows out from the liquid outlet of the temperature control rod, and then flows into the outer cooling liquid storage cavity to keep the temperature of the temperature bath medium at a predetermined level, and then passes through the cooling liquid. The liquid outlet of the storage tank flows through the return end of the temperature controller and enters the temperature controller cycle.
有益效果beneficial effect
本发明首次提出控冰材料需同时兼具与水和冰的亲和性,可在冰水界面吸附并铺展以更有效的抑制冰晶生长这一控冰机制,并提出一种新的控冰材料筛选方法,所述筛选方法不单单评估化合物本身的性质,还通过水溶液以及冰水界面体系的建立,实现观察和/或表征冰晶生长及材料在冰表面的吸附,进而实现冰与控冰材料之间相互作用的定量化测量,全面评估不同控冰材料在不同浓度下对于冰和水的亲和性,为相应材料控冰性能的比较以及控冰材料在具体应用时所适用的浓度范围和控冰效果提供准确参考。本发明的方法操作简单,可定量化测量,准确性高,改善了现有的通过纳升渗透压仪测定热滞后等实验方法操作复杂、难以定量的局限。The invention proposes for the first time that the ice control material needs to have both affinity with water and ice, and can adsorb and spread at the ice-water interface to more effectively inhibit the growth of ice crystals. This is the ice control mechanism, and proposes a new ice control material. The screening method not only evaluates the properties of the compound itself, but also realizes the observation and/or characterization of the growth of ice crystals and the adsorption of materials on the ice surface through the establishment of an aqueous solution and an ice-water interface system, thereby realizing the relationship between ice and ice-controlling materials. Quantitative measurement of the interaction between different ice control materials, comprehensive evaluation of the affinity of different ice control materials for ice and water at different concentrations, comparison of the ice control performance of corresponding materials, and the applicable concentration range and control of ice control materials in specific applications. Ice effect provides accurate reference. The method of the invention has simple operation, can be quantitatively measured, and has high accuracy, and improves the limitations of the existing experimental methods such as measuring thermal hysteresis by a nanoliter osmometer, which are complicated in operation and difficult to quantify.
附图说明Description of drawings
图1:实施例1中不同浓度的a-PVA和i-PVA在水溶液中的分散尺寸分布;Fig. 1: the dispersion size distribution of different concentrations of a-PVA and i-PVA in aqueous solution in Example 1;
图2:冰吸附实验及其装置示意图;Figure 2: Schematic diagram of ice adsorption experiment and its device;
图3:实施例1两种PVA的冰吸附量随浓度变化图;Fig. 3: The ice adsorption amount of two kinds of PVA of
图4:两种PVA在DPBS溶液中冰晶生长的光学显微图片,A为a-PVA,B为i-PVA。Figure 4: Optical micrographs of ice crystal growth of two PVA in DPBS solution, A is a-PVA and B is i-PVA.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的保护范围。此外,应理解,在阅读了本发明所公开的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本发明所限定的保护范围之内。The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and not to limit the protection scope of the present invention. In addition, it should be understood that after reading the content disclosed in the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the protection scope defined by the present invention.
下述实施例中所使用的实验方法如无特殊说明,均为常规方法;下述实施例中所用的试剂、材料等,如无特殊说明,均可从商业途径得到。The experimental methods used in the following examples are conventional methods unless otherwise specified; the reagents, materials, etc. used in the following examples can be obtained from commercial sources unless otherwise specified.
实施例1Example 1
a-PVA:分子量约为13~23kDa,间同规整度r(diad syndiotacticity)约为55%(Sigma-Aldrich);a-PVA: The molecular weight is about 13-23kDa, and the syndiotacticity r (diad syndiotacticity) is about 55% (Sigma-Aldrich);
i-PVA:分子量约为14~26kDa,全同规整度m(isotacticity)约为84%。i-PVA: The molecular weight is about 14-26 kDa, and the isotacticity m (isotacticity) is about 84%.
(1)测定两种PVA与水的亲和性(1) Determination of the affinity of the two PVAs with water
两种PVA在25℃水溶液中的粒径分布采用动态光散射(DLS)实验测量,实验仪器为带有恒温腔室和4mW He-Ne激光(λ=632.8nm)的Nano ZS(Malvern Instruments),其中散射角为173°。首先,分别配制浓度为1.0mg mL-1、4.0mg mL-1、10mg mL-1、20mg mL-1的a-PVA和i-PVA水溶液;将约1.0mL的PVA溶液装入12mm的一次性用聚苯乙烯比色皿进行测量。The particle size distributions of the two PVAs in aqueous solution at 25°C were measured by dynamic light scattering (DLS) experiments using Nano ZS (Malvern Instruments) with a constant temperature chamber and a 4mW He-Ne laser (λ=632.8nm). where the scattering angle is 173°. First, prepare a-PVA and i-PVA aqueous solutions with concentrations of 1.0 mg mL -1 , 4.0 mg mL -1 , 10 mg mL -1 , and 20 mg mL -1 respectively; about 1.0 mL of the PVA solution is loaded into a 12 mm disposable Measurements were made with polystyrene cuvettes.
结果如图1所示,相同浓度的a-PVA在水溶液中的分散尺寸远小于i-PVA。即,相比于a-PVA,i-PVA在水溶液中更倾向于以聚集状态存在。可见,上述a-PVA具有更好的水亲和性。The results are shown in Figure 1. The dispersion size of a-PVA in aqueous solution with the same concentration is much smaller than that of i-PVA. That is, i-PVA is more likely to exist in an aggregated state in an aqueous solution than a-PVA. It can be seen that the above a-PVA has better water affinity.
(2)测定两种PVA在冰水界面的铺展性能(2) Determination of the spreading properties of the two PVAs at the ice-water interface
采用冰吸附实验测定PVA在冰表面的吸附量,实验装置如图2所示。The adsorption amount of PVA on the ice surface was determined by the ice adsorption experiment. The experimental setup is shown in Figure 2.
a.将a-PVA和i-PVA用FITC Isomer I荧光标记。a. a-PVA and i-PVA were fluorescently labeled with FITC Isomer I.
b.将FITC标记的不同浓度PVA水溶液(40mL)置于烧杯中,将烧杯置于循环冷槽中并将溶液温度以及控温棒冷却到-0.1℃。b. The FITC-labeled PVA aqueous solutions (40 mL) of different concentrations were placed in a beaker, the beaker was placed in a circulating cold tank, and the solution temperature and the temperature control rod were cooled to -0.1°C.
c.将控温棒插入到事先冷却的FITC标记的PVA水溶液中之前,先将控温棒插入液氮中预冷1.0分钟。之后,再快速的将控温棒插入已经预冷的FITC标记的PVA水溶液里,以便在控温棒表面诱导一层极薄的冰层以诱导冰的生长。c. Before inserting the temperature control rod into the pre-cooled FITC-labeled PVA aqueous solution, insert the temperature control rod into liquid nitrogen to pre-cool for 1.0 minutes. After that, the temperature control rod was quickly inserted into the pre-cooled FITC-labeled PVA aqueous solution to induce a very thin ice layer on the surface of the temperature control rod to induce ice growth.
d.FITC标记的PVA水溶液在过冷温度-0.1℃下持续磁力搅拌1.0小时,以待PVA逐渐吸附到冰的表面。所有吸附实验保持过冷度以及吸附时间不变以此确保所得冰的表面积在误差允许范围内几乎不变。d. The FITC-labeled PVA aqueous solution was continuously magnetically stirred at a supercooled temperature of -0.1 °C for 1.0 hours, until the PVA was gradually adsorbed to the surface of the ice. The subcooling degree and the adsorption time were kept constant for all adsorption experiments to ensure that the surface area of the resulting ice was almost constant within the error tolerance.
e.将形成的冰块从溶液中取出,并用纯水淋洗表面以除去附着在表面的溶液。将冰块融化。e. Remove the formed ice cubes from the solution and rinse the surface with pure water to remove the solution adhering to the surface. Melt the ice cubes.
f.PVA在冰表面的吸附量由冰块中溶质PVA的质量比原始溶液中溶质PVA的质量获得,PVA溶液的浓度由紫外可见分光光度法确定,体积由移液枪以及量筒确定。f. The adsorption amount of PVA on the ice surface is obtained by the mass of the solute PVA in the ice cube to the mass of the solute PVA in the original solution. The concentration of the PVA solution is determined by UV-Vis spectrophotometry, and the volume is determined by a pipette gun and a graduated cylinder.
冰吸附实验显示各浓度的a-PVA和i-PVA吸附量如图3所示,a-PVA在冰表面的吸附量由0.2mg mL-1浓度时的16.3%增加到1.0mg mL-1的28.7%,并且在浓度大于1.0mg mL-1后,a-PVA在冰表面的吸附量达到饱和,饱和时吸附量约为36.5%。i-PVA在浓度小于1.0mgmL-1时冰吸附量为0%~19.3%,低于同浓度下a-PVA在冰表面的吸附量。在低浓度时,两种PVA对冰的吸附皆未达到饱和,i-PVA覆盖的冰表面积低于a-PVA。Ice adsorption experiments show that the adsorption amounts of a-PVA and i-PVA at various concentrations are shown in Figure 3. The adsorption amount of a-PVA on the ice surface increased from 16.3% at the concentration of 0.2 mg mL -1 to 1.0 mg mL -1 . 28.7%, and after the concentration was greater than 1.0 mg mL -1 , the adsorption amount of a-PVA on the ice surface reached saturation, and the adsorption amount was about 36.5% at saturation. When the concentration of i-PVA is less than 1.0 mgmL -1 , the ice adsorption capacity is 0%~19.3%, which is lower than the adsorption capacity of a-PVA on the ice surface at the same concentration. At low concentrations, the adsorption of ice on both PVAs was not saturated, and the ice surface area covered by i-PVA was lower than that of a-PVA.
当i-PVA浓度≥1.2mg mL-1吸附在冰面上的量高于a-PVA,并在2.0mg mL-1时i-PVA在冰面上的吸附量达到饱和,饱和时的吸附量为56.5%。进一步说明,两种PVA对相同大小的冰表面吸附覆盖达到饱和时,所需i-PVA的量远大于a-PVA。也就是说a-PVA可以更有效的覆盖冰的表面。When the concentration of i-PVA ≥ 1.2 mg mL -1 , the amount of adsorption on the ice surface is higher than that of a-PVA, and when the concentration of i-PVA is 2.0 mg mL -1 , the adsorption amount of i-PVA on the ice surface reaches saturation, and the adsorption amount when saturated was 56.5%. It is further explained that the amount of i-PVA required is much larger than that of a-PVA when the adsorption coverage of the two PVAs on the ice surface of the same size reaches saturation. That is to say, a-PVA can cover the ice surface more effectively.
(3)冰晶重结晶抑制(IRI)活性测量(3) Ice crystal recrystallization inhibition (IRI) activity measurement
冰晶重结晶抑制(IRI)活性采用“溅射冷冻法”,将上述两种PVA分别溶解分散到DPBS溶液中,将10~30μL所述溶液在1.0m以上的高度滴加到-60℃预冷的干净硅片表面,利用冷热台以10℃min-1的速度缓慢升温到-6℃,并在该温度下退火30min,利用偏光显微镜以及高速摄像机观察记录冰晶的大小,冷热台密封,保证内部的湿度在50%左右。每一个样品重复至少三次,使用Nano Measurer 1.2统计冰晶的尺寸,结果的误差为标准偏差。The ice crystal recrystallization inhibition (IRI) activity adopts the "sputter freezing method". The above two kinds of PVA are dissolved and dispersed in the DPBS solution respectively, and 10-30 μL of the solution is added dropwise at a height of 1.0 m or more to -60 ℃ pre-cooling The surface of the clean silicon wafer was slowly heated to -6°C at a rate of 10°C min -1 using a hot and cold stage, and annealed at this temperature for 30 min. The size of the ice crystals was observed and recorded with a polarizing microscope and a high-speed camera, and the hot and cold stage was sealed. Make sure the humidity inside is around 50%. Each sample was repeated at least three times, and the size of the ice crystals was counted using Nano Measurer 1.2. The error of the results was the standard deviation.
结果如图4所示,a-PVA冰晶尺寸明显小于同浓度时i-PVA的冰晶尺寸,说明a-PVA抑制冰晶生长的能力远远优于i-PVA。The results are shown in Figure 4. The ice crystal size of a-PVA is significantly smaller than that of i-PVA at the same concentration, indicating that the ability of a-PVA to inhibit the growth of ice crystals is much better than that of i-PVA.
根据实施例1的结果可以看出,i-PVA与水的亲和性较a-PVA弱。因此,i-PVA在水溶液以及冰水界面倾向于以聚集状态存在,而a-PVA在水溶液以及冰水界面可以很好的铺展。两种PVA对相同大小的冰表面吸附覆盖达到饱和时,所需i-PVA的量远高于a-PVA。因此,a-PVA与i-PVA相比,是更好的控冰材料,较低浓度即能起到更好的抑制冰晶生长的效果。According to the results of Example 1, it can be seen that the affinity of i-PVA with water is weaker than that of a-PVA. Therefore, i-PVA tends to exist in an aggregated state in aqueous solution and ice-water interface, while a-PVA can spread well in aqueous solution and ice-water interface. The amount of i-PVA required is much higher than that of a-PVA when the adsorption coverage of the two PVAs on the ice surface of the same size reaches saturation. Therefore, compared with i-PVA, a-PVA is a better ice control material, and a lower concentration can play a better effect on inhibiting the growth of ice crystals.
应用实验例1Application experiment example 1
冷冻保存液100mL:将2.0g上述a-PVA在80℃水浴中加热并磁力搅拌溶于25mL的DPBS中,待a-PVA全部溶解并冷却到室温后调节pH为7.0,为溶液1;17g(0.05mol)的蔗糖(蔗糖在冷冻保存液中终浓度为0.5mol L-1)超声溶解于25mL的DPBS中,待蔗糖全部溶解后加入10mL乙二醇、7.5mL的DMSO,为溶液2,待溶液1及溶液2恢复至室温,再将两种溶液混匀,调节pH值并定容补齐余量至总体积的80%,20mL的血清单独存放待保存液使用时添加。100 mL of cryopreservation solution: 2.0 g of the above-mentioned a-PVA was heated in a water bath at 80°C and dissolved in 25 mL of DPBS with magnetic stirring. After the a-PVA was completely dissolved and cooled to room temperature, the pH was adjusted to 7.0, which was
冷冻平衡液100mL:将7.5mL的乙二醇、7.5mL的DMSO溶于65mL的DPBS中,混匀,使用时加血清使其终浓度为20%(v/v)。100 mL of frozen equilibration solution: dissolve 7.5 mL of ethylene glycol and 7.5 mL of DMSO in 65 mL of DPBS, mix well, and add serum to make the
冷冻保存后用于解冻的解冻液为目前医疗机构普遍使用的商业化配方:解冻液Ⅰ(含有1.0mol L-1蔗糖,20%的血清,余量为DPBS);解冻液Ⅱ(含有0.5mol L-1蔗糖,20%的血清,余量为DPBS);解冻液Ⅲ(含有0.25mol L-1蔗糖,20%的血清,余量为DPBS);解冻液Ⅳ(20%的血清,余量为DPBS)。The thawing solution used for thawing after cryopreservation is a commercial formula commonly used by medical institutions at present: Thawing Solution I (containing 1.0mol L -1 sucrose, 20% serum, and the balance is DPBS); Thawing Solution II (containing 0.5mol L-1 sucrose, the balance is DPBS); L -1 sucrose, 20% serum, the balance is DPBS); Thawing Solution III (containing 0.25mol L -1 sucrose, 20% serum, the balance is DPBS); Thawing Solution IV (20% serum, the balance is for DPBS).
采用上述配方所制备的冷冻保存液和冷冻平衡液对小鼠的卵母细胞进冷冻保存。本发明所用卵母细胞冷冻保存方法具体为卵母细胞先置于冷冻平衡液平衡5分钟,然后置于上述配方所制备冷冻保存液45秒,将已在冷冻保存液中平衡的卵母细胞放置于冷冻载杆上,然后快速投入液氮(-196℃)中,并封闭载杆后继续保存;将卵母细胞置于37℃的解冻液Ⅰ中平衡3分钟,再依次在解冻液II-IV中各平衡3分钟;将解冻完毕的卵母细胞培养2小时,发现存活率为100%。而采用现有的常规配方(平衡液:每1mL中含有7.5%(v/v)的DMSO,7.5%(v/v)的乙二醇,20%(v/v)的胎牛血清,余量为DPBS;冷冻保存液:每1mL中含有15%(v/v)的DMSO,15%(v/v)的乙二醇,20%(v/v)的胎牛血清,0.5M蔗糖,余量为DPBS),小鼠卵母细胞存活率大约为95%。表明该含有a-PVA的冷冻保存液在将DMSO含量降低50%的前提下,仍能实现冷冻保存卵母细胞并复苏后具有更高的存活率,也证实了a-PVA是优良的冷冻保存材料。Cryopreservation of mouse oocytes was carried out using the cryopreservation solution and freezing balance solution prepared by the above formula. Specifically, the oocyte cryopreservation method used in the present invention is that the oocyte is first placed in the cryopreservation solution for equilibration for 5 minutes, then placed in the cryopreservation solution prepared by the above formula for 45 seconds, and the oocyte that has been equilibrated in the cryopreservation solution is placed in the cryopreservation solution. Place the oocytes on the frozen carrier rod, and then quickly put them into liquid nitrogen (-196°C), and seal the carrier rod for further storage; place the oocytes in 37°C Thawing Solution I for 3 minutes, and then place the oocytes in Thawing Solution II- Equilibrate in IV for 3 minutes each; thawed oocytes were cultured for 2 hours and found to be 100% viable. However, using the existing conventional formula (balance solution: 7.5% (v/v) DMSO, 7.5% (v/v) ethylene glycol, 20% (v/v) fetal bovine serum per 1 mL, the remaining The amount is DPBS; cryopreservation solution: each 1mL contains 15% (v/v) DMSO, 15% (v/v) ethylene glycol, 20% (v/v) fetal bovine serum, 0.5M sucrose, The balance is DPBS), and mouse oocyte viability is approximately 95%. It is shown that the cryopreservation solution containing a-PVA can still achieve cryopreservation of oocytes and have a higher survival rate after resuscitation under the premise of reducing the content of DMSO by 50%. It also confirms that a-PVA is an excellent cryopreservation. Material.
以上,对本发明的实施方式进行了说明。但是,本发明不限定于上述实施方式。凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The embodiments of the present invention have been described above. However, the present invention is not limited to the above-described embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
Claims (12)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910282418.9A CN111795909B (en) | 2019-04-09 | 2019-04-09 | Method for screening ice control material |
US17/594,340 US20220192179A1 (en) | 2019-04-09 | 2020-03-02 | Biomimetic ice-inhibiting material and cryopreservation solution comprising same |
AU2020256938A AU2020256938B2 (en) | 2019-04-09 | 2020-03-02 | Biomimetic ice-inhibiting material and cryopreservation liquid containing same |
KR1020217036485A KR20210142751A (en) | 2019-04-09 | 2020-03-02 | Bionic ice control material and cryopreservation solution containing same |
PCT/CN2020/077472 WO2020207150A1 (en) | 2019-04-09 | 2020-03-02 | Biomimetic ice-inhibiting material and cryopreservation liquid containing same |
JP2021560635A JP7389138B2 (en) | 2019-04-09 | 2020-03-02 | Bionic ice control material and cryopreservation solution containing this bionic ice control material |
SG11202110868XA SG11202110868XA (en) | 2019-04-09 | 2020-03-02 | Biomimetic ice-inhibiting material and cryopreservation solution comprising same |
EP20786705.2A EP3928862A4 (en) | 2019-04-09 | 2020-03-02 | BIOMIMETIC ICE-INHIBITING MATERIAL AND CRYOPRESERVATION FLUID CONTAINING SAME |
JP2023195336A JP2024023322A (en) | 2019-04-09 | 2023-11-16 | Bionic ice control material and cryopreservation solution containing this bionic ice control material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910282418.9A CN111795909B (en) | 2019-04-09 | 2019-04-09 | Method for screening ice control material |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111795909A true CN111795909A (en) | 2020-10-20 |
CN111795909B CN111795909B (en) | 2022-04-08 |
Family
ID=72805374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910282418.9A Active CN111795909B (en) | 2019-04-09 | 2019-04-09 | Method for screening ice control material |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111795909B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112509647A (en) * | 2020-11-27 | 2021-03-16 | 易波 | Hydrophilic interface selection system and method for holding biological tissue |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1627055A (en) * | 2003-12-08 | 2005-06-15 | 安黎哲 | Method for separating and detecting antifreeze protein of alpine periglacial plant, and equipment |
CN101391170A (en) * | 2007-09-19 | 2009-03-25 | 中国科学院金属研究所 | A low temperature pressure swing adsorption device |
CN103319563A (en) * | 2012-03-22 | 2013-09-25 | 东北农业大学 | Extraction and purification method of soyasaponins |
CN105664873A (en) * | 2016-04-05 | 2016-06-15 | 南华大学 | Method for adsorbing thorium by utilizing fiber-bridged beta-cyclodextrin derivative |
CN106544385A (en) * | 2015-09-16 | 2017-03-29 | 上海理工大学 | The separation method of collagen antifreeze peptide |
-
2019
- 2019-04-09 CN CN201910282418.9A patent/CN111795909B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1627055A (en) * | 2003-12-08 | 2005-06-15 | 安黎哲 | Method for separating and detecting antifreeze protein of alpine periglacial plant, and equipment |
CN101391170A (en) * | 2007-09-19 | 2009-03-25 | 中国科学院金属研究所 | A low temperature pressure swing adsorption device |
CN103319563A (en) * | 2012-03-22 | 2013-09-25 | 东北农业大学 | Extraction and purification method of soyasaponins |
CN106544385A (en) * | 2015-09-16 | 2017-03-29 | 上海理工大学 | The separation method of collagen antifreeze peptide |
CN105664873A (en) * | 2016-04-05 | 2016-06-15 | 南华大学 | Method for adsorbing thorium by utilizing fiber-bridged beta-cyclodextrin derivative |
Non-Patent Citations (1)
Title |
---|
QI CHENG: "Modifying Surfaces with the Primary and Secondary Faces of Cyclodextrins To Achieve a Distinct Anti-icing Capability", 《LANGMUIR》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112509647A (en) * | 2020-11-27 | 2021-03-16 | 易波 | Hydrophilic interface selection system and method for holding biological tissue |
CN112509647B (en) * | 2020-11-27 | 2022-09-06 | 易波 | Hydrophilic interface selection system and method for holding biological tissue |
Also Published As
Publication number | Publication date |
---|---|
CN111795909B (en) | 2022-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Meryman et al. | Freezing injury from “solution effects” and its prevention by natural or artificial cryoprotection | |
US9538745B2 (en) | Methods for the cryopreservation of cells | |
JP6099808B2 (en) | Vitrification freezing carrier of biological sample and use thereof | |
Ozkavukcu et al. | Cryopreservation: basic knowledge and biophysical effects | |
Mullen et al. | Human oocyte vitrification: the permeability of metaphase II oocytes to water and ethylene glycol and the appliance toward vitrification | |
CN104488853B (en) | A kind of ox embryo vitrifying freeze gets rid of pipe and thaws and directly transplanting method | |
JP2004503473A (en) | Cryopreservation of bioactive materials using high-temperature freezing | |
Gavish et al. | Cryopreservation of whole murine and porcine livers | |
CN112674078A (en) | Ultrasonic hepatocyte ice-planting cryopreservation device and cryopreservation method thereof | |
US20100212331A1 (en) | Cryopreservation method and device | |
CN111795909B (en) | Method for screening ice control material | |
GB2330516A (en) | Cryopreservation of cell suspensions | |
CN109892321A (en) | A kind of method of large volume biological sample cryo-conservation | |
Liu et al. | Exploring the application and mechanism of sodium hyaluronate in cryopreservation of red blood cells | |
Mazur et al. | Intracellular ice formation in mouse oocytes subjected to interrupted rapid cooling | |
CN108739795A (en) | A kind of fat stem cell frozen stock solution and its cryopreservation methods | |
WO2024164853A1 (en) | Vitrification freeze-thawing solution kit | |
EP2611290B1 (en) | Method for cryopreservation of human spermatozoa free from seminal plasma using a fast and simple aseptic vitrification-devitrification process | |
Baicu et al. | Vitrification of carotid artery segments: an integrated study of thermophysical events and functional recovery toward scale-up for clinical applications | |
US20080268492A1 (en) | Methods for Determining Optimal Techniques for Vitrification of Isolated Cells | |
CN106982820B (en) | Method for freezing Schwann cells by compound cryopreservation system | |
CN101215548B (en) | Human oocyte sequence vitrification refrigerating fluid and melting fluid | |
Quinn | Suppression of ice in aqueous solutions and its application to vitrification in assisted reproductive technology | |
Liu et al. | Engineered Supercooling Systems for Enhanced Long-Term Preservation of Large-Volume Red Blood Cells in Commercial Blood Bags | |
CN103704205B (en) | A kind of ox sperm freezing dilution liquid containing trace rare-earth and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220831 Address after: 100176 1607-3, 13 / F, building 13, yard 8, Ronghua Middle Road, Beijing Economic and Technological Development Zone, Daxing District, Beijing Patentee after: Beijing Dai Na Mi Ke Biotechnology Co.,Ltd. Address before: 100190 No. 2 North First Street, Haidian District, Beijing, Zhongguancun Patentee before: INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES Patentee before: PEKING UNIVERSITY THIRD Hospital |
|
TR01 | Transfer of patent right |